Compugen
CGEN
#8897
Rank
HK$1.10 B
Marketcap
HK$11.75
Share price
-6.21%
Change (1 day)
-5.03%
Change (1 year)

Revenue for Compugen (CGEN)

Revenue in 2025 (TTM): HK$53.77 Million

According to Compugen's latest financial reports the company's current revenue (TTM ) is HK$53.73 Million. In 2024 the company made a revenue of HK$0.21 Billion a decrease over the revenue in the year 2023 that were of HK$0.26 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Compugen from 2000 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) HK$53.77 M-75.14%
2024 HK$0.21 B-17.22%
2023 HK$0.26 B345.94%
2022 HK$58.59 M25.25%
2021 HK$46.78 M201.76%
2020 HK$15.5 M
2019 N/A-100%
2018 HK$0.13 B
2017 N/A-100%
2016 HK$5.52 M-92.32%
2015 HK$71.91 M-25.03%
2014 HK$95.92 M248.56%
2013 HK$27.52 M1367.12%
2012 HK$1.87 M
2011 N/A-100%
2010 HK$8.67 M347.64%
2009 HK$1.93 M-25.78%
2008 HK$2.61 M
2004 HK$31.29 M-54.26%
2003 HK$68.41 M-20.95%
2002 HK$86.53 M-2.3%
2001 HK$88.58 M56.46%
2000 HK$56.61 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Seagen
SGEN
HK$17.90 B 33,223.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
HK$0 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$130.59 B 242,924.77%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Genetic Technologies
GENE
HK$0.13 B 147.76%๐Ÿ‡ฆ๐Ÿ‡บ Australia